D
Fulcrum Therapeutics, Inc. FULC
$7.63 -$0.02-0.26% NASDAQ
Recommendation
Prev Close
$7.63
Volume
527,265
Avg Vol (90D)
638,044
Market Cap
$412.92M
Dividend & Yield
--
52-Week Range
$2.32 - $10.11
P/E (TTM)
--
EPS (TTM)
-$1.19
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/7/2025 - GuruFocus
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/7/2025 - Globe Newswire
Fulcrum Therapeutics (FULC) Receives Buy Rating and $20 Price Target from Stifel
11/6/2025 - GuruFocus
Fulcrum Therapeutics resumed with a Buy at Stifel
11/6/2025 - The Fly
Fulcrum Therapeutics (FULC, $7.87) price may climb as it broke lower Bollinger Band on Nov 05, 2025
11/6/2025 - Tickeron - Stocks
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Average Recommendation of "Moderate Buy" by Analysts
11/5/2025 - MarketBeat
Fulcrum Therapeutics (FULC, $9.02) Stochastic Oscillator left the oversold zone on November 03, 2025
11/4/2025 - Tickeron - Stocks
We Did The Math PSC Can Go To $69
11/4/2025 - ETF Channel
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle ...
11/3/2025 - GuruFocus
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
11/3/2025 - Globe Newswire
FY2025 EPS Estimate for Fulcrum Therapeutics Cut by Analyst
11/3/2025 - MarketBeat
FY2025 EPS Forecast for Fulcrum Therapeutics Cut by Analyst
11/3/2025 - MarketBeat
What is Leerink Partnrs' Estimate for FULC FY2025 Earnings?
11/3/2025 - MarketBeat
Fulcrum Therapeutics (NASDAQ:FULC) Stock Rating Lowered by Wall Street Zen
11/2/2025 - MarketBeat
What is HC Wainwright's Estimate for FULC Q1 Earnings?
11/1/2025 - MarketBeat
Fulcrum Therapeutics (NASDAQ:FULC) Price Target Raised to $7.00
10/31/2025 - MarketBeat
Fulcrum Therapeutics (FULC, $8.6) Aroon Indicator entered an Uptrend on October 30, 2025.
10/31/2025 - Tickeron - Stocks
Fulcrum Therapeutics' Earnings Call Highlights Progress and Potential
10/31/2025 - TipRanks Financial Blog
Fulcrum Therapeutics Inc (FULC) Q3 2025 Earnings Call Highlights: Promising Advances in Sickle ...
10/30/2025 - GuruFocus
Q3 2025 Fulcrum Therapeutics Inc Earnings Call Transcript
10/30/2025 - GuruFocus
RBC Capital Updates Fulcrum Therapeutics (FULC) Price Target Amidst Sector Perform Rating ...
10/30/2025 - GuruFocus
Fulcrum Therapeutics (NASDAQ:FULC) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS
10/30/2025 - MarketBeat
Piper Sandler Raises Price Target on Fulcrum Therapeutics (FULC) FULC Stock News
10/30/2025 - GuruFocus
Fulcrum Therapeutics price target raised by $3.50 at Piper Sandler, here's why
10/30/2025 - The Fly
Fulcrum Therapeutics (NASDAQ:FULC) Sets New 1-Year High - Should You Buy?
10/29/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$0.00
EBITDA (TTM)
-$80.09M
EBIT (TTM)
-$81.51M
Net Income (TTM)
-$71.11M
Balance Sheet
Total Assets (Q)
$214.86M
Total Debt (Q)
$7.01M
Total Liabilities (Q)
$16.49M
Book Value Per Share (Q)
$3.67
Cash Flow
Cash from Operations (TTM)
-$60.03M
Cash from Investing (TTM)
$34.03M
Cash from Financing (TTM)
$448.00K
Net Change in Cash (TTM)
-$25.55M
Filings
Filing Date
Wednesday, October 29, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
1.30
7-Day Total Return
-11.28%
30-Day Total Return
-12.00%
60-Day Total Return
11.88%
90-Day Total Return
10.26%
Year to Date Total Return
57.64%
1-Year Total Return
118.62%
2-Year Total Return
82.97%
3-Year Total Return
18.29%
5-Year Total Return
-29.48%
52-week Low
Apr 07, 2025 - $2.32
52-week High
Oct 28, 2025 - $10.11
Valuation
Market Cap
$412.92M - Small Cap
Enterprise Value
$219.29M
Price/Sales (TTM)
--
Price/Book (Q)
2.08
Dividends and Shares
Shares Outstanding
62.60
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.fulcrumtx.com
Phone Number
617 651 8851
Address
26 Landsdowne Street
Cambridge, MA 02139
Country
United States
Year Founded
2015
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet... more
NASDAQ 11/07/2025 4:00PM Eastern Quotes delayed